Longitudinal Autoantibody and Proteomic Signatures of Disease Progression in Systemic Sclerosis
Objective To evaluate dynamic changes in autoantibody and proteomic profiles in treatment‐naïve patients with systemic sclerosis (SSc) and to identify biomarkers and mechanisms associated with disease progression. Methods Serum samples from 30 baseline and 49 follow‐up patients…